首页|甲氨蝶呤联合艾拉莫德治疗女性中重度活动类风湿关节炎患者的疗效及对卵巢功能影响的研究

甲氨蝶呤联合艾拉莫德治疗女性中重度活动类风湿关节炎患者的疗效及对卵巢功能影响的研究

扫码查看
目的:探讨甲氨蝶呤(methotrexate,MTX)联合艾拉莫德(iguratimod,IGU)治疗女性中重度活动类风湿关节炎(rheumatoid arthritis,RA)患者的疗效及对卵巢功能的影响.方法:选取2020 年1 月—2022 年1 月在浙江大学医学院附属金华医院风湿免疫科确诊的80 例女性中重度活动RA患者为研究对象,随机分为MTX组及MTX+IGU组(各40 例),随访观察24 周,分别在第0 和24 周记录患者关节肿胀数、关节压痛数、晨僵时间、月经周期;检测患者类风湿因子、炎性指标、细胞因子水平等并计算DSA28-ESR评分.月经周期d3 检测卵巢储备功能指标,包括血清抗缪勒管激素、卵泡刺激素、促黄体生成素、雌二醇,B超检测窦状卵泡计数及测量卵巢体积.采用SPSS 22 软件分析治疗前后两组患者的疗效指标及卵巢功能相关指标变化.结果:治疗后MTX+IGU组较MTX组关节肿胀数(P<0.05)、关节压痛数(P<0.05)、红细胞沉降率(P<0.001)及DSA28-ESR评分(P<0.01)缓解更明显,白细胞介素-1β及白细胞介素-6 水平下降更显著(P<0.05).治疗后两组患者血清抗缪勒管激素水平均较治疗前升高,MTX+IGU组具有统计学差异(P<0.01),MTX组无统计学差异(P>0.05).其他卵巢功能相关指标变化未见统计学差异(P>0.05).结论:MTX联合IGU治疗女性中重度活动RA患者的疗效显著优于单用MTX,且不增加对女性卵巢功能的负面影响,甚至可能通过更有效地控制RA疾病活动状态从而改善女性患者的卵巢储备功能.
Combination therapy of methotrexate and iguratimod for female patients with moderate to severe active rheumatoid arthritis and its impact on ovarian function
Objective:To evaluate the combined efficacy of methotrexate(MTX)and iguratimod(IGU)for female patients with moderate to severe rheumatoid arthritis(RA)and its impact on ovarian function.Methods:Eighty female patients diagnosed with moderate to severely active RA and enrolled in our department from Jan 2020 to Jan 2022 were selected and randomly divided into MTX and MTX+IGU groups,with 40 patients in each group.The swollen joint count(SJC),tender joint count(TJC),duration of morning stiffness and menstrual cycle were recorded at week 0 and week 24,respectively.The patients'rheumatoid factor(RF),liver and kidney function,and cytokines were tested,and the DSA28-ESR score was calculated.On the 3rd day of menstrual cycle,ovarian reserve indicators,anti-Mullerian hormone in serum(AMH),follicle stimulating hormone(FSH),luteotropic hormone(LH)and estradiol(E2)were measured.The antral follicle counting(AFC)and ovary volume(OV)were measured by B-ultrasound specialists.SPSS 22 was used to analyze the efficacy and ovarian function-related indicators before and after treatment in the two groups of patients.Results:After treatment,the MTX+IGU group showed more obvious relief in SJC(P<0.05),TJC(P<0.05),ESR(P<0.001)and DSA28-ESR(P<0.01)score than MTX group,and the MTX+IGU group showed lower levels of IL-1β,IL-6 after treatment as compared to MTX group(P<0.05),with statistical significance.The two groups showed significantly higher level of AMH at the end of treatment,with statistical differences in the MTX+IGU group(P<0.01),no statistical differences in the MTX group(P>0.05).However,no statistical differences were observed in other ovarian function related indicators between the two groups(P>0.05).Conclusion:The combination therapy of MTX and IGU has significantly better efficacy for female patients with moderate to severe active RA than MTX alone,with less impact on female ovarian function,and even improves ovarian reserve function in female patients through more effective control of RA activity.

rheumatoid arthritismethotrexateiguratimodovarian functioninflammation

王颖芳、陈芳、王柳青、杜红卫、徐琛、唐飞

展开 >

浙江大学医学院附属金华医院 风湿免疫科,金华 321000

浙江大学医学院附属金华医院 超声科,金华 321000

妇浙江大学医学院附属金华医院 产科,金华 321000

类风湿关节炎 甲氨蝶呤 艾拉莫德 卵巢功能 炎症

浙江省金华市科技计划重点项目浙江省金华市科技计划公益项目浙江省金华市科技计划公益项目

2020-3-0522020-4-0052019-4-018

2024

中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
年,卷(期):2024.33(16)